Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,733 | 8,974 | 24,796 | 26,382 | 31,176 |
| Marketable Securities | 10,200 | 15,747 | N/A | N/A | N/A |
| Receivables | 540 | 401 | 381 | 279 | 81 |
| TOTAL | $25,326 | $27,448 | $29,273 | $30,860 | $34,376 |
| Non-Current Assets | |||||
| PPE Net | 251 | 274 | 291 | 307 | 318 |
| Other Non-Current Assets | 538 | 995 | 287 | 344 | 401 |
| TOTAL | $789 | $1,269 | $578 | $651 | $719 |
| Total Assets | $26,115 | $28,717 | $29,850 | $31,511 | $35,095 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,650 | 2,808 | 2,545 | 1,709 | 1,618 |
| Other current liabilities | 36 | 61 | 38 | 25 | 54 |
| TOTAL | $1,825 | $3,035 | $2,809 | $1,992 | $1,914 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,254 | 5,298 | 5,284 | 5,421 | 5,533 |
| TOTAL | $5,254 | $5,298 | $5,284 | $5,421 | $5,533 |
| Total Liabilities | $7,079 | $8,332 | $8,093 | $7,413 | $7,447 |
| Shareholders' Equity | |||||
| Common Shares | 302,637 | 310,788 | 305,000 | 310,739 | 313,080 |
| Retained earnings | -313,929 | -321,719 | -313,909 | -317,382 | -315,993 |
| Other shareholders' equity | 487 | 509 | 554 | 355 | 3,126 |
| TOTAL | $19,035 | $20,385 | $21,758 | $24,098 | $27,648 |
| Total Liabilities And Equity | $26,114 | $28,717 | $29,850 | $31,511 | $35,095 |